A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis
Status:
Recruiting
Trial end date:
2023-06-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of INCB054707 in
participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment
period, followed by a 24 -week single blind extension period.